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Infection of JLS-V9 cells in culture with Rauscher murine leukemia virus
induced the appearance on the cell surface of two classes of viral proteins:
Rauscher murine leukemia virus gp7O, and glycoproteins related to the viral core
(gag) proteins with apparent molecular weights in sodium dodecyl sulfate poly-
acrylamide gels of 80 x 103 and 95 x 103. The latter proteins were identified by
lactoperoxidase-catalyzed iodination of the cell surface and by metabolic labeling
with [3H]mannose followed by immunoprecipitation with an antiserum directed
against the major viral core protein, p30. Tryptic peptide maps of chloramine T-
iodinated proteins indicated that 80 x 103- and 95 x 103-molecular-weight proteins
were closely related. The 95 x 103-molecular-weight protein from Rauscher
murine leukemia virus-infected cells had a tyrosine fingerprint which was identical
to that of the 95 x 103-molecular-weight gag surface polyprotein of endogenous
virus-producing AKR-A cells, suggesting that expression on the cell surface of
glycosylated forms ofgag precursor polyproteins may not be an exclusive property
of leukemic thymocytes, but a more general phenomenon in murine leukemia
virus infection. Tryptic fingerprint analysis of iodinated viral and cell-bound
gp7O's before and after desialylation indicated a lower level of glycosylation in the
cell-bound gp7O population than in virions. Analysis of only surface-iodinated
gp7O showed a simple pattern of exposed tryptic peptides which was very similar
in Rauscher murine leukemia virus-infected cells and in AKR-A cells.
Cells infected with oncornaviruses contain vi-
rus-specific structural proteins which are syn-
thesized from the viral gene gag, coding for the
internal (core) proteins,pol, coding for the RNA-
dependent DNA polymerase, and env, coding for
the envelope proteins. Their biosynthesis occurs
through the processing of their respective pre-
cursor proteins, as demonstrated first for the
gag genes of avian (38, 39) and murine (24, 36)
viruses and reviewed by Eisenman and Vogt (6).
In cells infected with murine leukemia viruses
(MuLV), the viral envelope glycoprotein gp7O
was shown to be present on the cell surface by
immunological and biochemical methods (3, 12,
13, 20). This finding can be explained by the
membrane location of the final virus assembly,
which occurs by budding (27) and is thought to
require gp7O (2, 40). However, endogenous gly-
coproteins closely related to viral gp7O are also
found on certain mouse cells without concomi-
tant virus production (8, 21, 30, 31), and in the
form of GlX antigen they participate in the nor-
mal phenotypic differentiation of thymocytes of
low-leukemia strains of mice (3, 29, 33, 34).
MuLV envelope glycoprotein has recently been
implicated in the process of leukemogenesis (7,
32).
In addition to gp7O, a class of gag-related
surface proteins with molecular weights of 95 x
103 (95 k) and 85k has been described on AKR
leukemic cells (20, 35) and identified as the
"Gross cell surface antigen" (18, 28). They rep-
resent glycosylated forms of gag precursor
polyproteins that are not incorporated into virus
particles (19). Their role is obscure at present,
but their localization on the cell surface indicates
a possibility for immunological recognition.
Since these gag molecular species have been
identified currently only on thymocytes, we
wished to investigate whether they represent a
general phenomenon in MuLV infection. In this
paper we studied gag- and gp7O-related proteins
on the surface of cells in culture that had been
infected with the exogenous Rauscher MuLV
(R-MuLV). This investigation was prompted by
a finding by P. Nobis (personal communication)
that complement-mediated cytotoxicity against
the same R-MuLV-infected cells could be
achieved with an antiserum directed against the
R-MuLV major gag protein, p30. The present
analysis by surface iodination and immunopre-
cipitation identified on the surface of R-MuLV-
infected JLS-V9 cells two gag polyproteins of
approximately 80 and 95 kilodaltons. Tryptic
fingerprinting of the iodinated proteins revealed
that they are related to each other and identical,
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in this type of analysis, to endogenous (AKR)
virus-specified polyproteins. A similar study of
the envelope glycoprotein gp7O showed that cell-
bound gp7O was related to that of purified R-
MuLV, with some differences due to sialylation.
MATERIALS AND METHODS
Cels. JLS-V9 cels (44), a line derived from bone
marrow of a BALB/c mouse, were obtained from H.
Fan (Salk Institute, San Diego, Calif.) through P.
Nobis (presently at H. Pette Institute, Hamburg, West
Germany). AKR-A cells (43) were obtained from R.
B. Herberman (National Institutes of Health, Be-
thesda, Md.) through J.-C. Cerottini (Ludwig Institute,
Epalinges, Switzerland). They were grown in Dul-
becco-modified Eagle medium containing 5% heat-in-
activated (56°C, 45 min) fetal calf serum in 10-cm
plastic petri dishes (Corning Glass Works).
Virus. R-MuLV (cell passage 9 in JLS-V9 cells)
was obtained from G. P. Shibley (Frederick Cancer
Research Center, Frederick, Md.) and was propagated
in the same cells. Tissue culture supernatants (kept at
-70°C) were used for newly infecting JLS-V9 cells
when seeded. Infected cells were used for experiments
between passages 2 and 7 after infection. Virus was
purified from tissue culture medium by sedimentation
and equilibrium centrifugation in 15 to 60% sucrose
gradients in 0.1 M NaCl-0.05 M Tris-hydrochloride
(pH 7.5)-i mM EDTA.
Antisera. Goat antisera prepared against purified
proteins of R-MuLV were obtained from the National
Cancer Institute, Bethesda, Md., and kindly provided
by R. Wilsnack: anti-p30, lot 2S-658; anti-gp 70, lot 5S-
129. Their specificity was tested by immunoprecipita-
tion of [3S]methionine-labeled R-MuLV and sodium
dodecyl sulfate (SDS)-gel electrophoresis.
Cell surface labeling. JLS-V9 cell monolayers
(about 80% confluent) were dispersed by incubation in
phosphate-buffered saline containing 10 mM EDTA
for 10 to 15 min at 37°C. In early experiments (see Fig.
1 and 2) they were trypsinized briefly and allowed to
recover in suspension in medium containing 10% fetal
calf serum for 3 to 5 h at 37°C. AKR-A cells and
dispersed JLS-V9 cells were washed repeatedly and
radioiodinated by the method of Vitetta et al. (37)
with some modifications. To about 5 x 107 to 7 x 107
cells in 1 ml of Earle saline, 100 ug of lactoperoxidase
(Sigma Chemical Co.) and 1 to 2 mCi of "I were
added, followed by three additions, at 4-min intervals,
of 25 p1 of 0.06% H202; the tube was kept in gentle
rotation at 20'C. Labeling was stopped by dilution
with phosphate-buffered saline containing 10 mM po-
tassium iodide and 0.1 mg of phenylmethylsulfonyl
fluoride (Sigma) per ml. The cells were washed several
times with the same buffer and then lysed in 20 mM
Tris-hydrochloride (pH 7.5)-50 mM NaCl containing
0.5% Nonidet P40, 0.5% deoxycholate, and 0.1 mg of
phenylmethylsulfonyl fluoride per ml for 30 min on
ice. After blending in a Vortex mixer for 30 s, nuclei
were removed by centrifugation at 13,000 x g for 10
min, and the supernatant was further clarified at
100,000 x g for 45 min and then used immediately for
immunoprecipitation.
Intracellular labeling. R-MuLV-infected JLS-V9
cells were labeled with 200 jLCi of [3H]mannose per
plate in culture medium for 23 h, washed with cold
phosphate-buffered saline, and scraped in lysis buffer.
The lysate was centrifuged at 13,000 x g for 10 min,
and the supernatant was used for immunoprecipita-
tion.
Immunoprecipitation. The lysate (1 ml) was
preadsorbed with 50 p1 of fixed Staphylococcus aureus
(10% suspension; prepared by the method of Kessler
[15]). In some experiments, 0.1% SDS was added to
reduce nonspecific binding during immunoprecipita-
tion. About 5 pl of antiserum per plate equivalent was
added; incubation was for 1 h at 37°C. Immune com-
plexes were precipitated with a 10-fold excess of S.
aureus suspension in 0.15 M NaCI-5 mM EDTA-50
mM Tris-hydrochloride (pH 7.5) (NET) plus 0.05%
Nonidet NP-40, washed three times in the same buffer
and once in NET without Nonidet P-40, and finally
eluted with gel sample buffer (0.1 M Tris-hydrochlo-
ride [pH 7]-20% glycerol-4% SDS-0.02% bromophenol
blue) for 15 min at room temperature.
Polyacrylamide gel electrophoresis. Samples
were solubilized by heating at 100°C for 2 to 3 min in
sample buffer containing 10% 2-mercaptoethanol and
subjected to electrophoresis in 10% discontinuous
SDS-polyacrylamide slab gels (17), cross-linked with
diallyltartardiamide (1). Electrophoresis at 30 mA was
stopped when the bromophenol blue marker reached
the bottom of the slab. Gels were briefly fixed and
stained with Coomassie brilliant blue in 50% trichlo-
roacetic acid and destained in 7% acetic acid-30%
methanol. After soaking for 1 to 2 h in water, individual
lanes of the slab were cut out and sliced (two 1-mm
slices per fraction) for counting. "nI-labeled proteins
were counted directly in a gamma counter. 3H-labeled
proteins were eluted from gel slices for 24 h at room
temperature in 0.2 M ammonium carbonate (pH 8.5)
containing 0.1% SDS, diluted with water-solubilizing
scintillation fluid (Aquasol; New England Nuclear
Corp.), and counted in a liquid scintillation counter.
lodination and tryptic peptide analysis ofpro-
teins. Chloramine T iodination of proteins in gel slices
was performed by the method of Elder et al. (9). The
removal of terminal sialic acid residues from glycopro-
teins (4, 16) was performed before iodination by incu-
bating the gel slices in 2 ml of 0.05 N H2SO4 at 80°C
for 90 min. After iodination and extensive washing,
the gel slices were dissolved in 2% periodic acid; the
proteins were precipitated with 25% trichloroacetic
acid and 100 ug of bovine serum albumin as a carrier
and washed as described by Gibson (11). The protein
preparations were then oxidized with 0.5 ml of 0.1 M
H202 for 2 h at room temperature, lyophilized, and
digested with trypsin as reported previously (39). The
separation of tryptic peptides was obtained by chro-
matography at 50°C on a column of Chromobead P
(Technicon Corp., Inc.) cation-exchange resin which
was eluted with a quadratic gradient of acetic acid-
pyridine between pH 2.5 and 4.5 as described previ-
ously (16, 39). Fractions (3 ml each) were counted
directly in a Packard gamma counter. After each run,
the column was washed with the pH 4.5 column buffer
containing 10 mg of potassium iodide per ml to remove
any residual free iodine. Tritium label was counted
with Aquasol (New England Nuclear Corp.) scintilla-
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tion fluid after evaporating the column buffer and
dissolving the samples in 0.01 N HCI. Values were
corrected for '25I overlap in the tritium channel.
RESULTS
Virus-related proteins on the surface of
R-MuLV-infected celis. R-MuLV-infected
JLS-V9 cells were surface labeled with 125I and
lactoperoxidase and then lysed with Nonidet P-
40 and deoxycholate. Labeled proteins were im-
munoprecipitated with antisera directed against
R-MuLV protein p30 or gp70 and analyzed by
electrophoresis in acrylamide gels (Fig. 1). Anti-
gp7O serum precipitated one protein species of
approximately 70 kilodaltons (Fig. 1B). Anti-p30
serum (Fig. 1A) precipitated two main species,
one of approximately 80 kilodaltons and a more
heterogeneous one of approximately 90 to 95
kilodaltons. The smaller peak at about 45 kilo-
daltons was probably cellular actin that adhered
to the immune complexes. The relative amount
of label incorporated into the 80 and 95k proteins
was always 10 to 25 times less than that incor-
porated into the 70k species. All ofthese proteins
were glycosylated; Fig. 1 also shows the super-
imposed pattem (obtained in a separate experi-
ment) of 80 and 95k proteins metabolically la-
beled with [3H]mannose. When surface-labeled
uninfected and R-MuLV-infected JLS-V9 cells
were compared (Fig. 2), both possessed a 70k
protein in comparable amounts, whereas 80 and
95k proteins were detectable only in infected
cells. Since the 70k protein of infected cells was
precipitated by anti-gp70 serum and comigrated
on gels with viral gp7O, we considered it to be
viral envelope glycoprotein gp70 expressed on
the cell surface. Uninfected-cell gp7O is probably
due to the expression of an endogenous gp7O-
related gene (8, 21). Since the 80 and 95k pro-
teins were precipitated by an antiserum directed
against the major gag protein p30, we tenta-
tively called them "gag surface polyproteins" by
analogy with those described by others (20, 35)
on the surface of leukemia cells, although their
migration in gels with respect to protein markers
was slightly different.
Tryptic peptide mapping of gag surface
polyproteins from R-MuLV-infected cells.
Both polyproteins were recognized by anti-p30
serum and contained, therefore, p30 determi-
nants. Their high molecular weight suggests that
they contained more amino acid sequences, pos-
sibly of other gag proteins. To determine
whether these sequences were the same, we com-
pared their tyrosine tryptic fingerprints. 80 and
95k gag proteins were re-iodinated in vitro with
chloramine T, oxidized, and digested with tryp-
sin, and the resulting peptides were separated
on a cation-exchange chromatography column.
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FIG. 1. SDS-polyacrylamide slab gel electropho-
resis of immunoprecipitates from surface-iodinated,
R-MuLV-infected JLS-V9cells. (A) Nine-tenths ofthe
preparation immunoprecipitated with anti-p30 serum
(continuous line). Superimposed is the pattern of a
[3H]mannose-labeled anti-p30 immunoprecipitate
(broken line) obtained in a separate experiment. (B)
One-tenth of the preparation precipitated with anti-
gp7O serum. Arrows indicate theposition ofunlabeled
molecular weight markers electrophoresed in neigh-
boring slots. Left to right: phosphorylase a (97 kilo-
daltons), bovine serum albumin (68 kilodaltons), and
immunoglobulin G, heavy chain (50 kilodaltons).
Figure 3A and B shows that the two proteins
had essentially identical fingerprints: all eight
clearly identifiable peptides in one protein were
present in the other, and no major peptide dif-
ference between them could be found. When
tryptic digests of 80 and 95k proteins were mixed
in equal amounts and chromatographed to-
gether, the same number of peaks and the same
overall pattern of the single components were
obtained (data not shown). The fingerprint of
these gag proteins was different from that of
surface-labeled, re-iodinated gp70 shown below
(see Fig. 5A). This confirmed that the polypro-
teins precipitated by anti-p30 antiserum were
not contaminated by gp70, although this protein
was much more abundant on the cell surface.
The difference in apparent molecular weight
on gels between 80 and 95k might have been due
J. VIROL.
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FIG. 2. SDS-polyacrylamide slab gel electropho-
resis of immunoprecipitates from surface-iodinated
uninfected (A and B) and R-MuLV-infected (C and
D) JLS- V9 cells. (A) and (C) show anti-gp70 precipi-
tates (1/10 ofthepreparation); (B) and (D) show anti-
p30 precipitates (9/10 of the preparation). Molecular
weight markers as in Fig. 1.
to peptides not containing tyrosine or to glyco-
sylation, which could also have interfered with
in vitro labeling, digestion, or peptide separation.
The second hypothesis was tested by performing
the same analysis on 80 and 95k proteins that
had been treated with sulfuric acid to remove
terminal sialic acid residues (4, 16). This treat-
ment did not cause peptide breakage when
tested on proteins with a known fingerprint (un-
published data). A comparison of the finger-
prints showed that acid treatment did not affect
the position of the peptides, except for one: peak
g in Fig. 3A was absent in acid-treated 95k,
whereas a new peak, g' (Fig. 4A), appeared at
about five fractions to the right, which was pos-
sibly the same peptide eluting now at a slightly
more basic pH.
4.
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Relationship ofgag surface proteins from
R-MuLV-infected cells to endogenous virus
gag surface polyproteins. Since the 80 and
95k proteins appeared on the cell surface after
R-MuLV infection, they could carry some R-
type specificity, or they could be the expression
of endogenous viral information. In any case, we
were interested in knowing to what extent these
proteins were related to those present on the
surface of leukemia cells expressing endogenous
virus and previously identified serologically as
Gross cell surface antigen. We therefore com-
pared iodinated tryptic fingerprints of 95k gag
proteins from R-MuLV-infected JLS-V9 cells
and endogenous virus-producing AKR-A cells
that had been surface labeled and immunopre-
cipitated with anti-p30 antiserum. (InAKR cells,
only one prominent band comigrating with the
phosphorylase marker was present in the im-
mune precipitates, whereas no distinct peak was
seen at the position of 80 kilodaltons.) Figure 4
shows the two chromatographic elution patterns
of the acid-treated 95k proteins. They in-
clude an intemal tritiated marker of a protein
with a known fingerprint that was mixed with
the iodinated sample before analysis; this al-
lowed us to compare the exact position of peaks
independently of experimental variations in the
pH gradient. We concluded that the two finger-
prints were identical, not only in the eight major
tryptic peptides (identified with the same letters
as in Fig. 3), but also in the minor features of
the pattem. Two independent preparations of
each type of cells gave identical results, and a
mixture (in approximately equal amounts of ra-
dioactivity) of iodinated 95k from R-MuLV-in-
fected cells and AKR cells produced a finger-
print with the same pattem as either of the
individual components. These results show that
the gag surface proteins of R-MuLV-infected
JLS-V9 cells and of AKR-A cells are highly
related and possibly identical, since no difference
between them could be detected by iodinated
tryptic peptide analyses.
Viral glycoprotein gp7O. As a control to the
data obtained for gag proteins, we wished to
verify to which viral type the glycoprotein gp7O
belonged. A similar type of analysis was there-
fore performed on the viral glycoproteins im-
munoprecipitated with anti-gp70 antiserum and
re-iodinated with chloramine T. gp7O from R-
MuLV-infected JLS-V9 cells had a tryptic fin-
gerprint (Fig. 5A) that was clearly different from
that of gp7O ofAKR-A cells (Fig. 5C) and closely
resembled that of R-MuLV gp7O (see below).
Figure 5A and C shows the patterns of "native,"
untreated gp7O's. A comparison with the pattern
obtained after the removal of terminal sialic acid
residues (4, 16) gives some clues about the state
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FIG. 3. Chloramine T-iodinated trypticpeptides of80k (A) and 95k (B) proteins. R-MuLV-infected JLS- V9
cells were surface iodinated and lysed, and the labeled polyproteins in an anti-p30 immunoprecipitate were
isolated by electrophoresis on a gel that was sliced and counted. Thepolyproteins were re-iodinated in thegel
slice and then isolated by trichloroacetic acid precipitation after dissolving the gel as described in the text.
The H202-oxidized proteins were digested with trypsin, and peptides were separated by chromatography on
a Chromobead P cation-exchange column. Corresponding peptides are indicated by lowercase letters.
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FIG. 4. Comparison of tryptic fingerprints of 95k proteins from R-MuLV-infected JLS-V9 cells (A) and
AKR-A cells (B). Surface-iodinated proteins were precipitated from the cell lysate with anti-p30 serum and
isolated by SDS-gel electrophoresis. 95k proteins were acid treated (to remove terminal sialic acid residues),
re-iodinated with chloramine T, trichloroacetic acid precipitated after dissolving the gel slice, oxidized, and
digested with trypsin as described in the text. For the cation-exchange chromatography, iodinated tryptic
digests ( ) were mixed with tryptic digests of [3HJlysine-labeled vpl9 from avian myeloblastosis virus as
an internal marker (---).
of glycosylation of the different proteins. In the a slight change in the fingerprint: peptide i dis-
case of R-MuLV-infected cells, treatment with appeared and a new peptide (q) appeared,
acid to remove terminal sialic acid caused only whereas the other 13 major peptides (b, c, d, e,
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FIG. 5. Comparison of tryptic fingerprints of chloramine T-iodinated cell-bound gp70's: native (A) (- )
and acid-treated (B) R-MuLV-infected JLS-V9 cells andAKR-A cells (C). gp7O was immunoprecipitated with
anti-gp7O serum from surface-iodinated cells, isolated by SDS-gel electrophoresis, relabeled with chloramine
T, andprocessed for tryptic fingerprinting as described in the text. (A) (---) also shows the tryptic fingerprint
of acid-treated gp70 from purified R-MuLV, isolated by SDS-gel electrophoresis, iodinated, andprocessed as
the cellular samples. It was obtained in a separate run on the same column, and thepH gradients measured
on fractions ofeach profile were superimposable.
g, h, j, 1, m, o, p, r, and s) were identical before
and after acid treatment (Fig. 5B). The broken
line in Fig. 5A is the fingerprint of acid-treated
gp7O from R-MuLV grown in the same cells.
Eleven peptides (b, d, h, j, 1, m, o, p, q, r, and s)
were in common with cellular glycoprotein; four
cellular peptides (a, c, e, and g) were absent in
virus, whereas four new ones were found (f, k, n,
and t). These results suggest that the bulk of
cell-bound gp7O molecules had a different level
of glycosylation than did the gp7O in mature R-
MuLV particles (see below). Interestingly, for
AKR cells, the comparison of native and acid-
treated gp7O's also showed specific differences in
the fingerprints, suggesting the occurrence of
sialylated peptides in AKR gp7O, as well.
Finally, we tried to gather infornation about
the conformation of gp7O when it is inserted in
the cellular membrane by investigating its avail-
ability to surface labeling. Fingerprint analysis
of immunoprecipitated gp7O from surface-iodi-
nated cells was performed without previous re-
iodination in vitro. The result shows (Fig. 6) that
only a few (3 to 4) tryptic peptides were labeled
out of the 14 major ones found in the uniformly
iodinated protein (Fig. 5). One of them eluted in
the acidic part of the gradient near the flow
through of the column. Two highly labeled and
a minor one eluted in the position around pep-
tides d to g in Fig. 5A; the exact identification is
at present still open. In AKR cells, a similar
fingerprint was obtained (although with a some-
what higher background) despite the fact that
the uniformly labeled AKR gp7O had a finger-
print different from that of R-MuLV gp7O, as
shown in Fig. 5.
DISCUSSION
Glycosylated forms ofMuLVgag polyproteins
on the cell surface have been described in AKR
mouse thymocytes (20, 35) and Gross virus-in-
duced leukemia cells (18, 28). We wished to
determine whether this phenomenon was exclu-
sive to leukemic thymocytes or rather a general
result of MuLV infection. In this report we de-
scribed the presence on the cell surface of R-
MuLV-infected JLS-V9 cells of two related
forms ofglycosylatedgag proteins with apparent
molecular weights of.80 and 95k. We also showed
that uninfected cells did not have detectable
gag-related proteins on their surface, whereas
they possessed a gp7O-related protein that was
VOL. 33, 1980
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FIG. 6. Tryptic fingerprints of cell-bound gp7O's iodinated with lactoperoxidase on the surface ofAKR-A
(A) and R-MuLV-infected JLS-V9 (B) cells. Anti-gp7O immunoprecipitates from surface-labeled cells were
analyzed by SDS-gel electrophoresis. Gel slices containing the radioactive gp7O were dissolved, and the
protein was oxidized and trypsinized for chromatographic analysis as described in the text.
not analyzed further. The expression of gp7O
independently of virus production has been doc-
umented (21, 30, 31).
After this study was completed, the existence
of glycosylated gag-related proteins was shown
by metabolic labeling techniques in R-MuLV-
infected JLS-V9 cells by Schultz et al. (26) and
in Moloney MuLV-infected cells by Edwards
and Fan (5), similar to findings of Evans et al.
(10) in Friend MuLV-infected cells. In these
studies an incompletely glycosylated precursor
to gP949"9, gPr80g", was described as opposed
to gP859'9 which would derive from gP949ag (19).
The authors conclude from their data that all of
these molecules differ only in their glycosylation
level and have the same protein moiety; they are
discriminated mainly by their different kinetics
of intracellular labeling. Therefore, our analysis
does not allow a definitive conclusion as to
whether the 80k surface glycoprotein in this
study represents gPr80Iag or a derivative similar
to gP85 '.
The two molecular forms ofgag polyproteins
(80 and 95k) found on R-MuLV-infected JLS-
V9 cells had very similar maps of tyrosine-con-
taining tryptic peptides (Fig. 3); analogous ob-
servations have been reported for the Gross
leukemia gag polyproteins of 85 and 95k molec-
ular weight (19), using different labeled amino
acids. Variations in the glycosylation level could
be invoked to account for the different migration
in SDS gels. Although we did not observe
marked differences in the tryptic peptide map of
95k protein after the chemical removal of ter-
minal sialic acid residues (4, 16), differences in
intemal sugar residues, in peptides not resolved
by the column and eluting in the flow through,
or in peptides not containing tyrosine are still
possible.
Tryptic fingerprinting of the iodinated pro-
teins also showed that the 95k gag proteins on
the surface of R-MuLV-infected cells and AKR
leukemic cells were indistinguishable (Fig. 4),
whereas their cell surface gp70's could be clearly
distinguished (Fig. 5). One could assume that a
low level of endogenous virus production is in-
duced by the exogenous infection and could ac-
count for the presence of gag polyproteins on
the cell surface. However, the ratio of radioac-
tive 1"I incorporation into gp7O versus gag
polyproteins is approximately the same in R-
MuLV-infected cells and in AKR cells (20; E.
Buetti, unpublished data); if there were coordi-
nate expression of glycoproteins and polypro-
teins of the endogenous virus, one would expect
to see a significant contribution by the endoge-
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nous gp7O to the fingerprint ofR-MuLV-infected
cell glycoprotein. Such an overlap was not ob-
served (Fig. 5), suggesting that the presence of
gag surface polyproteins in R-MuLV-infected
cells was probably not due to the concomitant
production of an endogenous virus. Our results
can be compared with those obtained by
O'Donnell and Stockert (25) by using a different
experimental approach, namely, testing the abil-
ity of cells, when used for absorption, to reduce
cytotoxic titers of GIX and Gross cell surface
antigen antisera. Cultured fibroblasts infected
by exogenous MuLV gave negative absorption
of GLX antiserum (which detects an endogenous
form of gp7O), whereas they gave partial absorp-
tion of anti-Gross cell surface antigen reactivity
(directed against gag polyproteins).
The 95k gag polyproteins contain several gag
proteins with type specificity (19), which would
be different in AKR and R-MuLV-infected cells.
The identity of 95k proteins in our type of anal-
ysis may mean that type-specific peptides do not
contain tyrosine or that they are not resolved by
the column used or even that some are absent in
the 95k polyproteins (19). It is also possible that
the gag precursor is identical in different viruses
and that differences in the fingerprints of the
mature gag proteins could be the consequence
of different processing.
In summary, we have shown that the infection
of JLS-V9 cells in culture with R-MuLV induced
the appearance on the cell surface, in addition
to larger amounts ofR-MuLV gp7O glycoprotein,
of glycosylated forms of gag polyproteins. The
latter are therefore not an exclusive feature of
leukemic thymocytes (20, 35); their function in
the viral infective cycle, if any, must still be
elucidated.
Our chloramine T tryptic peptide analyses of
cell-bound gp70 glycoproteins showed an exten-
sive dissimilarity between R-MuLV-infected
cells and AKR cells, in agreement with pub-
lished data on the viral gp70's (8). However, the
fingerprints of the same proteins, when they had
only been iodinated in situ with lactoperoxidase,
were intriguingly similar (Fig. 6). Although the
chromatographic method used was not sufficient
to prove the identity of the peptides, the result
suggests a similarity at least in the charge, if not
in the sequence, ofthe portion ofprotein exposed
on the cell surface. A more detailed analysis
would be needed to clarify this point.
The treatment of glycoproteins with sulfuric
acid had been shown to be effective in removing
their terminal sialic acid residues (4, 16). In the
case of the avian glycoprotein gp85, this method
had helped to clarify a complex fingerprint that
was possibly due to heterogeneous sialylation
MuLV CELL SURFACE PROTEINS 943
(16). When we applied this treatment to viral
and cellular gp7O's (Fig. 5), we found specific
differences in individual peptides that can pro-
vide some information on the maturation proc-
ess of the virus. A recent report (23) analyzes
the sources of the heterogeneity of MuLV gp7O
as being both genetic and due to variability in
the number of sialic acid residues attached to
oligosaccharides (22). When we compared the
fingerprints of native and desialylated cell-
bound gp7O, we found relatively little difference
(one peptide displaced). This suggests a rela-
tively low level of sialylation on the whole cel-
lular gp7O population, which resides mainly in
the cell membrane (14, 42). On the contrary,
acid treatment of gp7O from purified virus re-
sulted in the displacement of four additional
peptides, suggesting a higher level of sialylation
in virions. This may also explain our inability to
obtain interpretable fingerprints of native gp7O
from purified virus (data not shown).
In summary, our data for R-MuLV-infected
cells are consistent with the existence of a large
pool of cell surface-bound gp7O molecules that
are incompletely glycosylated and a relatively
small number that is further sialylated and par-
ticipates in the budding of virus particles. Ki-
netic (41, 42) and immunoelectron microscopic
(14) evidence supports this interpretation.
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